"Strofantin" miyagun ƙwayoyi. Umarnin don amfani

Drug "Strofantin" yana nufin wani rukuni na cardiac glycosides. An shawarar for zuciya gazawar wasu fiye da m ko na kullum tsari, kazalika da paroxysmal tachycardia.

A medicament "Strofantin" wanda siffar rajista - bakarariya bayani, na physico-sinadaran Properties ne m ruwa cewa yana da wani launi. Babban aiki sashi daga cikin miyagun ƙwayoyi ne a cakuda cardiac glycosides samu daga magani shuke-shuke strophanthus iri.

A medicament "Strofantin", umarnin don amfani da gabatar da ta mataki samar cardiotonic sakamako, kara da gudun da kuma karfi na ƙanƙancewa na zuciya tsoka. A glycosides waɗanda sashi daga cikin miyagun ƙwayoyi, da inganta karin jini girma fitad ga tsokar ƙanƙancewa da daya ga wani minti daya. A zuciya rashin cin nasara medicament kara habaka na ramin zuciya emptying. Wannan rage infarction size, sai ya rage oxygen bukatar. A warkewa sakamako daga cikin miyagun ƙwayoyi auku a cikin uku zuwa minti goma bayan shi ne shigar da kuma yana daya zuwa kwanaki uku.

Drug "Strofantin" umurci manual da ya bayyana ta effects a jiki, yana da dukan asali pharmacological Properties mallaki by cardiac glycosides, amma, sabanin su, cardiotonic mataki da miyagun ƙwayoyi ne karfi da ta bayyana quite da sauri. Magani yana da kadan sakamako a kan myocardium kari kuma ba ya tsoma baki tare da aiwatar da hasken dake fitowa a cikin cuta reshe block. Shiri "Strofantin" umurci wanda ya bayyana da hanyar da ta amfani, da aka gudanar intravenously a kananan allurai. Saboda rashin zaman lafiya ya, ya nuna kadan warkewa sakamako a lokacin gudanar. Da miyagun ƙwayoyi ba tara a cikin jiki, duk da haka, zai iya sa wani mai guba dauki a hulda da Digitalis magunguna. Don kauce wa wannan sakamako, shi ne allura intravenously kawai bayan Digitalis magani wurare. A hutu dole ne daga hudu zuwa shida kwanaki. Kusan arba'in bisa dari na gudanar da miyagun ƙwayoyi ta ɗaure da sunadaran samu a jini jini. Babban aiki abubuwa excreted da kodan canzawa.

A medicament "Strofantin" (umurci manual bayyana ainihin Pathology a wadda ta bada shawarar yin amfani) aka nuna a zuciya rashin cin nasara, na biyu da na uku, saukarwa da ciwon na kullum, cuta infarction kari na supraventricular tachycardia, kazalika ga atrial arrhythmias.

Yana iya sa da miyagun ƙwayoyi da makaruhai illa a jiki. A mafi yawan lokuta, da suka faru a yawan abin sama, m igiyar jini gwamnati, kazalika ya karu ƙwarai daga cikin mutum haƙuri ga glycosides. M cardiac arrhythmias da kuma tsokar madugu. Shi ne kuma zai yiwu a zawo da amai da tashin zuciya, da kuma a musamman mai tsanani pathologies - mesenteric infarction. Matsalar aiki na samfur na ji gabobin da kuma tsakiya m tsarin zai iya haifar da bayyanar ciwon kai, ciki, hallucinations, psychosis, rashin barci da kuma na gani hanawa. A wasu lokuta, maza zai iya ci gaba gynecomastia. Akwai kuma yiwuwar rashin lafiyan halayen.

Drug "Strofantin" umarnin don amfani da gargadi akan contraindications ba nuna ga tsokar zuciya infarction, tare da m tsari, glycoside maye, na ramin zuciya tachycardia, ya furta bradycardia, hypercalcemia, kuma hypokalemia, marasa lafiya sinus ciwo, wani aneurysm na thoracic lakã, atrioventricular block biyu da na uku mataki.